Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |